Cargando…

HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

BACKGROUND: Despite a typically good response to first-line combination chemotherapy, the prognosis for patients with advanced ovarian cancer remains poor because of acquired chemoresistance. The use of targeted therapies such as trastuzumab may potentially improve outcomes for patients with ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuefferd, Marianne, Couturier, Jérôme, Penault-Llorca, Frédérique, Vincent-Salomon, Anne, Broët, Philippe, Guastalla, Jean-Paul, Allouache, Djelila, Combe, Martin, Weber, Béatrice, Pujade-Lauraine, Eric, Camilleri-Broët, Sophie
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042515/ https://www.ncbi.nlm.nih.gov/pubmed/17987122 http://dx.doi.org/10.1371/journal.pone.0001138

Ejemplares similares

Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)
por: Elie, C, et al.
Publicado: (2004)

Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study
por: Falandry, Claire, et al.
Publicado: (2015)

CXCL12 expression by healthy and malignant ovarian epithelial cells
por: Machelon, Véronique, et al.
Publicado: (2011)

A mixture model approach to multiple testing for the genetic analysis of gene expression
por: Dalmasso, Cyril, et al.
Publicado: (2007)

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO
por: Ray-Coquard, I, et al.
Publicado: (2013)

Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group
por: Ray-Coquard, I, et al.
Publicado: (2007)

Predicting tumor response and outcome of second-look surgery with (18)F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer
por: Aide, Nicolas, et al.
Publicado: (2020)

Finding exclusively deleted or amplified genomic areas in lung adenocarcinomas using a novel chromosomal pattern analysis
por: Broët, Philippe, et al.
Publicado: (2009)

Evaluation of the accuracy of the PLCO(m2012) 6-year lung cancer risk prediction model among smokers in the CARTaGENE population-based cohort
por: Jantzen, Rodolphe, et al.
Publicado: (2023)

Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset
por: DUCROS, ELODIE, et al.
Publicado: (2012)

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group
por: Ray-Coquard, I, et al.
Publicado: (2009)

Epidemiological characteristics of the COVID-19 spring outbreak in Quebec, Canada: a population-based study
por: Jantzen, Rodolphe, et al.
Publicado: (2021)

A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases
por: Hässler, Signe, et al.
Publicado: (2022)

Histerectomia en gineco-obstetricia
por: Rodríguez Velázquez, Rodolfo
Publicado: (1999)

Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification
por: Cayre, Anne, et al.
Publicado: (2007)

Gineco-obstetricia : de la niñez a la senectud
por: Mondragón Castro, Héctor
Publicado: (2006)

Hospital universitario de gineco-obstetricia /
por: Cadena Rojas, María Esther
Publicado: (1993)

Monografía de gineco-obstetricia prehispanica /
por: Pérez de Salazar, J. L.

Problemas gineco-obstétricos de la adolescencia. /
por: Vázquez García, Luz Arcelia
Publicado: (1996)

Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer
por: Arnould, L, et al.
Publicado: (2003)

Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma
por: Dalmasso, Cyril, et al.
Publicado: (2015)

Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
por: Pujade-Lauraine, Eric
Publicado: (2013)

First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study
por: Hardy-Bessard, Anne-Claire, et al.
Publicado: (2020)

A model-based statistic for detecting molecular markers associated with complex survival patterns in early-stage cancer
por: Broët, Philippe, et al.
Publicado: (2012)

Bagging survival tree procedure for variable selection and prediction in the presence of nonsusceptible patients
por: Mbogning, Cyprien, et al.
Publicado: (2016)

Métodos auxiliares en el diagnóstico gineco-obstétrico /
por: Rodríguez Hernández, Rosa Amada
Publicado: (1995)

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study
por: van de Vijver, Marc, et al.
Publicado: (2007)

Unidad medico integral de gineco.obstetricia Xalapa, Ver. /
por: Arias Pozos, Paloma Iveth
Publicado: (2006)

Temas selectos de gineco-obstetricia: libro homenaje ofrecido al prof. Dr. Alfonso Alvarez Bravo /

Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
por: Scheel, Andreas H., et al.
Publicado: (2018)

Identifying common prognostic factors in genomic cancer studies: A novel index for censored outcomes
por: Rouam, Sigrid, et al.
Publicado: (2010)

A pseudo-R(2 )measure for selecting genomic markers with crossing hazards functions
por: Rouam, Sigrid, et al.
Publicado: (2011)

Socio-Demographic Factors Associated With COVID-19 Vaccine Hesitancy Among Middle-Aged Adults During the Quebec's Vaccination Campaign
por: Jantzen, Rodolphe, et al.
Publicado: (2022)

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
por: Ledermann, Jonathan A., et al.
Publicado: (2019)

Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice
por: Dupouy, Sandra, et al.
Publicado: (2014)

Dehincencia de herida quirúrgica en la paciente gineco-obstétrica
por: Galindo Ortega, Lilia
Publicado: (1997)

Manual de procedimientos para el area de gineco-obstetricia
por: Villa Lara, María Guadalupe
Publicado: (1994)

A constrained polynomial regression procedure for estimating the local False Discovery Rate
por: Dalmasso, Cyril, et al.
Publicado: (2007)

A Rescue Strategy for Handling Unevaluable Patients in Simon’s Two Stage Design
por: Belin, Lisa, et al.
Publicado: (2015)

A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up
por: Belin, Lisa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t96nut6a1d6rtgj6fh3oovn5i0